News

Min Son of Hanol IP & Law analyses a ruling that clarifies the scope of patent infringement, territoriality limits, and ...
New York drugmaker Pfizer and Mainz, Germany, immunotherapy company BioNTech said the European Commission, which generally follows CHMP's advice, will now review the recommendation, with a final ...
Pfizer (NYSE:PFE) and BioNTech (NASDAQ:BNTX) have gained a positive opinion from the European Medicines Agency’s Committee ...
Pfizer-BioNTech's COVID-19 vaccine, which was once hailed as a lifesaver, has been found to have subtle but serious side ...
The US Department of Health and Human Services has adopted a recommendation to remove a preservative called thimerosal from all influenza vaccines distributed in the United States.
The Food and Drug Administration (FDA) has approved a new prefilled syringe presentation of Shingrix (zoster vaccine recombinant, adjuvanted).
Prefilled syringe eliminates the need to reconstitute separate vials prior to administration and simplifies the vaccine process.
The action will remove from use the very few flu shots that contain the contested preservative, elevating unproven fears it ...